CMS updates MRI eligibility for implanted cardiac devices

Matt O'Connor | | Health Imaging | Cardiac Imaging

CMS updated its National Coverage Determination (NCD) conditions granting MRI eligibility to Medicare beneficiaries with implanted pacemakers or cardioverter defibrillators, according to an American College of Radiology (ACR) release.

The policy update, which went into effect April 10, came after the American College of Cardiology (ACC) teamed up with the ACR, the Heart Rhythm Society and Society for Cardiovascular Magnetic Resonance to pen a letter supporting the proposed MRI expanded coverage.

The ACR press release provided a section of frequently asked questions to help clinicians begin providing MRI services to these patients. The group urged providers to email them with further questions at advocacy.acc.org.

""
Matt O'Connor

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Related Content

Global shortage of nuclear imaging isotopes may be over
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT
FDA clears AI tool that flags signs of heart disease in chest CT scans
AI-enabled plaque assessments help cardiologists ID high-risk CAD patients
Abbott CGM sensors can now be worn during common imaging procedures
New data highlight long-term benefits of HeartFlow’s AI-based CAD evaluations

Around the web

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business
FDA clears AI tool that flags signs of heart disease in chest CT scans

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup